title,year,conference
 Abcd-strategy: Budgeted experimental design for targeted causal structure discovery,2019, In The 22ndInternational Conference on Artificial Intelligence and Statistics
 Causalworld: A robotic manipulation bench-mark for causal structure and transfer learning,2020, arXiv preprint arXiv:2010
 Transcriptionalregulatory networks underlying gene expression changes in huntington¡¯s disease,2018, Molecular Sys-tems Biology
 Variational causal networks: Approximate bayesian inference over causalstructures,2021, arXiv preprint arXiv:2106
 Ensemble learning in bayesian neural networks,1998, Nato ASISeries F Computer and Systems Sciences
 Neuronlike adaptive elements that cansolve difficult learning control problems,1983, IEEE Transactions on Systems
 Learning and sampling of atomic interventions from observations,2020, In InternationalConference on Machine Learning
 Memory-assisted rein-forcement learning for diverse molecular de novo design,2020, Journal of Cheminformatics
 Random forests,2001, Machine Learning
 Guacamol: benchmarkingmodels for de novo molecular design,2019, Journal of chemical information and modeling
 Bayesimp:Uncertainty quantification for causal data fusion,2021, arXiv preprint arXiv:2106
 The riseof deep learning in drUg discovery,2018, Drug Discovery Today
 DiffUsion component analysis: Unraveling fUnc-tional topology in biological networks,2015, In International Conference on Research in Computa-tional Molecular Biology
 Compact integration of mUlti-network topology forfUnctional analysis of genes,2016, Cell Systems
 A machine learning approach for genome-wideprediction of morbid and drUggable hUman genes based on systems-level data,2010, In BMC Genomics
 Extracting biological insights from the project achilles genome-scale crispr screens in cancer cell lines,2019, bioRxiv
 Imagenet: A large-scalehierarchical image database,2009, In IEEE Conference on Computer Vision and Pattern Recognition
 Active learning for personalizing treatment,2011, In 2011IEEE Symposium on Adaptive Dynamic Programming and Reinforcement Learning (ADPRL)
 Key factors in the rising cost of new drUg discovery anddevelopment,2004, Nature Reviews Drug Discovery
 The cost of new drUg discovery and development,2009, Discov-ery Medicine
 Innovation in the pharmaceUticalindUstry: new estimates of r&d costs,2016, Journal of Health Economics
 PertUrb-seq: dissectingmolecUlar circUits with scalable single-cell rna profiling of pooled genetic screens,2016, Cell
 AUtomated versUs do-it-yoUrself methods for caUsal inference: Lessons learned from a data analysis competition,2019, Statis-tical Science
 Exploiting machine learning for end-to-end drug discoveryand development,2019, Nature Materials
 Dropout as a bayesian approximation: Representing modeluncertainty in deep learning,2016, In International Conference on Machine Learning
 Budgeted ex-periment design for causal structure learning,2018, In International Conference on Machine Learning
 Learning to navigate thesynthetically accessible chemical space using reinforcement learning,2020, In International Conferenceon Machine Learning
 Bradshaw: a system for automatedmolecular design,2020, Journal of Computer-aided Molecular Design
 Artificial intelligence for clinical trialdesign,2019, Trends in Pharmacological Sciences
 Multi-omics approaches to disease,2017, GenomeBiology
 TWo optimal strategies for active learning of causal models frominterventional data,2014, International Journal of Approximate Reasoning
 Clinicaldevelopment success rates for investigational drugs,2014, Nature Biotechnology
 Bayesian nonparametric modeling for causal inference,2011, Journal of Computationaland Graphical Statistics
 Keeping the neural netWorks simple by minimizing the de-scription length of the Weights,1993, In Proceedings of the Sixth Annual Conference on ComputationalLearning Theory
 Molecular design in synthetically accessible chemicalspace via deep reinforcement learning,2020, ACS omega
 Bayesian active learning forclassification and preference learning,2011, arXiv preprint arXiv:1112
 Causal-bald: Deep bayesian active learning of outcomes to infer treatment-effects fromobservational data,2021, Advances in Neural Information Processing Systems
 Learning neural causal modelsfrom unknown interventions,2019, arXiv preprint arXiv:1910
 A practical view of ¡®druggability¡¯,2006, CurrentOpinion in Chemical Biology
 Are drug targets with genetic support twice aslikely to be approved? revised estimates of the impact of genetic support for drug mechanisms onthe probability of drug approval,2019, PLoS Genetics
 Molecular generative model basedon conditional variational autoencoder for de novo molecular design,2018, Journal of Cheminformatics
 Microsoft coco: Common objects in context,2014, In EuropeanConference on Computer Vision
 Challenging common assumptions in the unsupervised learningof disentangled representations,4114, In international conference on machine learning
 Dibs: Differentiablebayesian structure learning,2021, arXiv preprint arXiv:2105
 Are ganscreated equal? a large-scale study,2017, arXiv preprint arXiv:1711
 A practical bayesian framework for backpropagation networks,1992, Neural Compu-tation
 Exploring intermediate cell states through the lensof single cells,2452, Current Opinion in Systems Biology
 Artificial intelligence in drug development: presentstatus and future prospects,2019, Drug Discovery Today
 Machine learning on human muscle transcriptomic data forbiomarker discovery and tissue-specific drug target identification,2018, Frontiers in Genetics
 Generating realisticin silico gene networks for performance assessment of reverse engineering methods,2009, Journal ofComputational Biology
 Active learning of causal bayes net structure,2001,2001
 The support of human geneticevidence for approved drug indications,2015, Nature Genetics
 A bayesian active learningexperimental design for inferring signaling networks,2017, In International Conference on Researchin Computational Molecular Biology
 Quantitative proteomics of the cancer cell line encyclopedia,2020, Cell
 Molecular de-novodesign through deep reinforcement learning,2017, Journal of Cheminformatics
 NCoRE: Neural Counterfactual RepresentationLearning for Combinations of Treatments,2021, arXiv preprint arXiv:2103
 Scikit-learn: Machine learning in Python,2011, Journal of Machine Learning Research
 Chess: a new human gene catalogcurated from thousands of large-scale rna sequencing experiments reveals extensive transcrip-tional noise,2018, Genome Biology
 Deep reinforcement learning for de novodrug design,2018, Science Advances
 Reinforced adversarial neural computer for de novomolecular design,2018, Journal of Chemical Information and Modeling
 Margin-based active learning for structured output spaces,2006, In EuropeanConference on Machine Learning
 Coupled single-cell crispr screening and epigenomic profiling reveals causal gene regulatory networks,2019, Cell
 Causalprotein-signaling networks derived from multiparameter single-cell data,2005, Science
 Genome-widecrispr screen identifies protein pathways modulating tau protein levels in neurons,2021, Communica-tions biology
 Diagnosing the decline inpharmaceutical r&d efficiency,2012, Nature Reviews Drug Discovery
 Learningneural causal models with active interventions,2021, arXiv preprint arXiv:2109
 Crispr activation and interference screens in primary human tcells decode cytokine regulation,2021, bioRxiv
 Perfect Match: A Simple Method forLearning Representations For Counterfactual Inference With Neural Networks,2018, arXiv preprintarXiv:1810
 Learn-ing Counterfactual Representations for Estimating Individual Dose-Response Curves,2020, In AAAIConference on Artificial Intelligence
 Active learning for convolutional neural networks: A core-setapproach,2017, arXiv preprint arXiv:1708
 Genome-wide crisprscreens in primary human t cells reveal key regulators of immune function,92, Cell
 Activelearning for decision-making from imbalanced observational data,2019, In International Conferenceon Machine Learning
 Active learning for structure in bayesian networks,2001, In InternationalJoint Conference on Artificial Intelligence
 Ensemble adversarial training: Attacks and defenses,2017, arXiv preprint arXiv:1705
 Defining cell types and states with single-cell genomics,2015, Genome Research
 Applications of machine learn-ing in drug discovery and development,2019, Nature Reviews Drug Discovery
 Global proteinfunction prediction from protein-protein interaction networks,2003, Nature biotechnology
 Estimation of clinical trial success rates andrelated parameters,2019, Biostatistics
 The unique molecular and cellular microenvironment of ovariancancer,2017, Frontiers in Oncology
 A genome-wide crispr screen identifies host factors that regulate sars-cov-2 entry,2021, Nature communications
 Genome-wide crispr screen reveals cancercell resistance to nk cells induced by nk-derived ifn-¦Ã,2019, Frontiers in Immunology
